Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Interviews as Topic × Clear all

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 22 Prostatic Neoplasms 10 Breast Neoplasms 10 Colorectal Neoplasms 9 Ovarian Neoplasms 6 Lung Neoplasms 5 Hematologic Neoplasms 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Rectal Neoplasms 2 Pain 2 Mouth Neoplasms 2 Fatigue 2 Endometrial Neoplasms 2 Depression 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Total Exenteration 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1

Interventions

Gemcitabine 25 Fluorouracil 22 Oxaliplatin 19 Cisplatin 18 Leucovorin 14 Bevacizumab 13 Paclitaxel 11 Capecitabine 11 130-nm albumin-bound paclitaxel 11 Docetaxel 10 Carboplatin 9 Albumin-Bound Paclitaxel 9 Irinotecan 8 pembrolizumab 6 Radiotherapy 6 Pemetrexed 6 Ramucirumab 5 Erlotinib Hydrochloride 5 Cyclophosphamide 5 Trastuzumab 4 Nivolumab 4 Everolimus 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3 Gefitinib 3 Esophagectomy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03963739 2025-07-16

PCW

Wake Forest University Health Sciences

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡